Open Menu Close Menu
CFO
  • News
  • Resources
  • Events
  • Webinars
  • CFO Magazine
Search

Danaher

Was GE’s New CFO a Risky Choice?

Carolina Dybeck Happe's background makes her an unusual choice to run finance at the struggling conglomerate, a research report suggests.

GE Stock Surges on News of Biopharma Sale

The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.

Why You Should Bring Customers to the M&A Table

Deal-makers often don’t consider customers, according to a global branding consultancy. When they do, everybody wins.

CFO
LinkedIn Facebook Twitter YouTube

Stay Updated

Sign up to our weekly newsletter

Email Address:

Topics

  • Accounting & Tax
  • Credit & Capital
  • Risk & Compliance
  • Strategy
  • Technology
  • Human Capital

Content

  • Homepage
  • News
  • Resources
  • Events
  • Webinars
  • CFO Magazine

About CFO

  • About CFO
  • Privacy Policy
  • Editorial Staff
  • Press
  • Advertise
  • Contact Us

Copyright © 2021 CFO. Industry Dive, Inc. (c) 2021, All rights reserved, 1255 23rd Street, NW, Suite 550, Washington, DC 20037